ReviewGalen medical journal2025
Long-Term Clinical Outcomes and Patient Satisfaction Following Ultrasound-Guided Hydrodissection for Carpal Tunnel Syndrome : Long-Term Outcomes and Satisfaction after Ultrasound-Guided Hydrodissection for CTS.
Review in Galen medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carpal Tunnel Syndrome (CTS) is popular conditions in where compression of the median nerve causes symptoms such as pain, numbness, and hand weakness in the hand. Current treatments provide varying degree of symptom relief; however, most are limited by short term response or long recovery. Ultrasound-Guided Hydrodissection (USGH) has emerged as a minimally invasive alternative for treating CTS, allowing precise injection of fluid around the median nerve under real-time ultrasound guidance to enhance nerve mobility. Complications of USGH are rare and mild, including short term pain, swelling, or bruising at the injection site. Because of the precision afforded by ultrasound guidance, serious complications, such as nerve damage or infection, are rare. This review aimed to evaluate the long-term clinical outcomes and patient satisfaction after USGH for CTS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.